Antihypertensive and Cardioprotective Evaluation of a Functional Olive Oil

Plain-language summary

This study evaluates the blood-pressure-lowering and heart-protective effects of a functional olive oil. It enrolled children and adolescents aged 6-18 who had arterial hypertension or very high risk and were not already on blood-pressure medication. It was a study without a phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Universidad de Granada

Intervention

Optimized oil group, Functional oil group, Control group

Start date

1/1/2022

Estimated completion

9/30/2024

Countries

Spain

Related genes

Locations

• Córdoba, Spain
• Granada, Spain

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Age between 6 and 18 years Percentile levels compatible with arterial hypertension or very high risk (SBP and/or DBP over P90) Without previous medication for hypertension Acceptance to participate by signing the informed consent

Exclusion Criteria:

Children under 6 years of age Absence of hypertension Children who require or receive some type of medication to control blood pressure, glucose levels or dyslipidemia or any probiotic Not to sign the informed consent.